Details of the Drug

General Information of Drug (ID: DMV20B8)

• Drug Name: FT538

Indication

Disease Entry	ICD 11	Status	REF
Acute myeloid leukaemia	2A60	Phase 1	[1]
Multiple myeloma	2A83	Phase 1	[1]

• Drug Type: Cell therapy
• Cross-matching ID: TTD ID: D79JZU
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] ClinicalTrials.gov (NCT04614636) FT538 in Subjects With Advanced Hematologic Malignancies. U.S. National Institutes of Health.